Literature DB >> 20033631

In vitro development of human Killer-Immunoglobulin Receptor-positive NK cells.

Frank Cichocki1, Jeffrey S Miller.   

Abstract

The in vitro culture system outlined in this chapter allows for the delineation of events that occur during the development of CD34(+) hematopoietic precursor cells into mature KIR(+) human NK cells. This system can also be utilized to study the effects of gene overexpression or knockdown on the process of NK cell differentiation through retroviral transduction and long-term culture. The necessary soluble factors and contact-dependent conditions for in vitro human NK cell development have been worked out in our laboratory over the past 16 years.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20033631     DOI: 10.1007/978-1-60761-362-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.

Authors:  Luxi Chen; Youssef Youssef; Cameron Robinson; Gabrielle F Ernst; Mary Y Carson; Karen A Young; Steven D Scoville; Xiaoli Zhang; Regine Harris; Palak Sekhri; Anthony G Mansour; Wing K Chan; Ansel P Nalin; Hsiaoyin C Mao; Tiffany Hughes; Emily M Mace; Yinghong Pan; Navin Rustagi; Sujash S Chatterjee; Preethi H Gunaratne; Gregory K Behbehani; Bethany L Mundy-Bosse; Michael A Caligiuri; Aharon G Freud
Journal:  Immunity       Date:  2018-09-04       Impact factor: 31.745

2.  Eomesodermin and T-bet mark developmentally distinct human natural killer cells.

Authors:  Amélie Collins; Nyanza Rothman; Kang Liu; Steven L Reiner
Journal:  JCI Insight       Date:  2017-03-09

3.  Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function.

Authors:  Steven D Scoville; Ansel P Nalin; Luxi Chen; Li Chen; Michael H Zhang; Kathleen McConnell; Susana Beceiro Casas; Gabrielle Ernst; Abd Al-Rahman Traboulsi; Naima Hashi; Monica Williams; Xiaoli Zhang; Tiffany Hughes; Anjali Mishra; Don M Benson; Jennifer N Saultz; Jianhua Yu; Aharon G Freud; Michael A Caligiuri; Bethany L Mundy-Bosse
Journal:  Blood       Date:  2018-08-29       Impact factor: 22.113

4.  Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.

Authors:  Steven A Dezell; Yong-Oon Ahn; Jan Spanholtz; Hongbo Wang; Matthew Weeres; Scott Jackson; Sarah Cooley; Harry Dolstra; Jeffrey S Miller; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-07       Impact factor: 5.742

5.  A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets.

Authors:  Steven D Scoville; Bethany L Mundy-Bosse; Michael H Zhang; Li Chen; Xiaoli Zhang; Karen A Keller; Tiffany Hughes; Luxi Chen; Stephanie Cheng; Stephen M Bergin; Hsiaoyin C Mao; Susan McClory; Jianhua Yu; William E Carson; Michael A Caligiuri; Aharon G Freud
Journal:  Immunity       Date:  2016-05-10       Impact factor: 31.745

6.  Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Authors:  Frank Cichocki; Martin Felices; Valarie McCullar; Steven R Presnell; Ahmad Al-Attar; Charles T Lutz; Jeffrey S Miller
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

7.  GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Authors:  Frank Cichocki; Bahram Valamehr; Ryan Bjordahl; Bin Zhang; Betsy Rezner; Paul Rogers; Svetlana Gaidarova; Stacey Moreno; Katie Tuininga; Phillip Dougherty; Valarie McCullar; Peter Howard; Dhifaf Sarhan; Emily Taras; Heinrich Schlums; Stewart Abbot; Daniel Shoemaker; Yenan T Bryceson; Bruce R Blazar; Scott Wolchko; Sarah Cooley; Jeffrey S Miller
Journal:  Cancer Res       Date:  2017-08-08       Impact factor: 12.701

8.  Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation.

Authors:  Martin Felices; Dave E M Ankarlo; Todd R Lenvik; Heather H Nelson; Bruce R Blazar; Michael R Verneris; Jeffrey S Miller
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

9.  Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

Authors:  Emily M Mace; Amy P Hsu; Linda Monaco-Shawver; George Makedonas; Joshua B Rosen; Lesia Dropulic; Jeffrey I Cohen; Eugene P Frenkel; John C Bagwell; John L Sullivan; Christine A Biron; Christine Spalding; Christa S Zerbe; Gulbu Uzel; Steven M Holland; Jordan S Orange
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

Review 10.  A research-driven approach to the identification of novel natural killer cell deficiencies affecting cytotoxic function.

Authors:  Michael T Lam; Emily M Mace; Jordan S Orange
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.